Prostate stem cell antigen (PSCA), first described by Reiter et al (4), is a surface glycoprotein that is upregulated in androgen-dependent and -independent prostate cancer xenografts and downregulated in the normal prostate (4). This evidence concerns the gene PSCA and prostate cancer.